TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05457036

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spry Belt
Description: The Spry Belt is a device worn around the hips which delivers gentle energy to the lower back. The level of energy is controlled by an internal microprocessor (computer) so that it is safe and comfortable. The energy is at a level that may or may not be perceptible to the user. The device is powered by an internal lithium-ion battery which must be recharged periodically. The device is designed to be used with its companion Spry app (via Bluetooth Low Energy (BLE)) so that anonymous usage statistics may be monitored. The expected shelf life of the device is longer than 2 years and the expected use life is at least 12-18 months.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Spry Belt
Description: The Sham Spry Belt is a device worn around the hips which does not deliver gentle energy to the lower back. The device instead provides a clicking noise similar to a motor. The device is powered by an internal lithium-ion battery which must be recharged periodically. The device is designed to be used with its companion Spry app (via BLE) so that anonymous usage statistics may be monitored. The expected shelf life of the device is longer than 2 years and the expected use life is at least 12-18 months.
Study: NCT06358547

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PGT-A
Description: PGT-A is a technique that allows for the prediction of embryo ploidy status through analysis of a trophectoderm biopsy conducted prior to embryo transfer.
Study: NCT06209723

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Description: Participants will follow a vegetarian diet during a period of five weeks
Study: NCT05759741

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIYAIRI 588
Description: 4 tablets of MIYAIRI 588 were inserted into the distal ileostomy once a week for 6 months
Study: NCT04972552

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: coenzyme Q10
Description: Participants will take 800-1200 mg of coenzyme Q10 capsule per day

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: coenzyme Q10
Description: Participants will take 800-1200 mg of coenzyme Q10 capsule per day

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Watermelon diet
Description: Participants will be asked to eat watermelon at a minimum of one meal per day 3-5 days a week

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Watermelon diet
Description: Participants will be asked to eat watermelon at a minimum of one meal per day 3-5 days a week

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Diet
Description: Participants will be asked to eat a usual diet but not eat any watermelon as part of their usual diet

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Usual Diet
Description: Participants will be asked to eat a usual diet but not eat any watermelon as part of their usual diet

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will be asked to take 800-1200 mg of a placebo capsule per day

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will be asked to take 800-1200 mg of a placebo capsule per day
Study: NCT06270004

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: nonsurgical periodontal therapy
Description: sonic scaler for scaling and polishing. Graces curettes numbers(1-2,3-4,5-6,7-8,9-10,11-12,13-14)for root surfaces debridement(RSD), instructions and motivation for dental arch

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: nonsurgical periodontal therapy
Description: sonic scaler for scaling and polishing. Graces curettes numbers(1-2,3-4,5-6,7-8,9-10,11-12,13-14)for root surfaces debridement(RSD), instructions and motivation for dental arch
Study: NCT05076578

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Autologous Regeneration of Tissue (ARTTM) system
Description: The ART Skin Harvesting System is intended to harvest full thickness skin microcolumns in a minimally invasive manner and scatter them at the recipient site. It consists of three components: (1) a non-sterile, reusable handheld device; (2) a sterile, single-patient use needle cartridge containing the needle array for harvesting skin micrografts from the patient donor site; and (3) a sterile, disposable handheld protective sleeve to cover the handheld device (figure 1). The sterile sleeve reduces contamination of the reusable handheld device and provides a sterile barrier between the non-sterile handheld device and the patient.
Study: NCT05664022

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Global postural reeducation
Description: The GPR involves a series of active gentle movements and postures aimed at realigning joints, stretching shortened muscles, and enhancing the contraction of antagonist's muscles, thus avoiding postural asymmetry.~The GPR method includes eight therapeutic postures, lying, sitting or standing, to be held for 15/20 minutes each. Postures can be variously combined during sessions. Postures are chosen on the basis of some parameters, such as the amount of pain, load capacity and age of the patient, and muscle chains to be stretched. to increase the standardization of treatment, it will be proposed only 2 or 3 postures.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Global postural reeducation
Description: The GPR involves a series of active gentle movements and postures aimed at realigning joints, stretching shortened muscles, and enhancing the contraction of antagonist's muscles, thus avoiding postural asymmetry.~The GPR method includes eight therapeutic postures, lying, sitting or standing, to be held for 15/20 minutes each. Postures can be variously combined during sessions. Postures are chosen on the basis of some parameters, such as the amount of pain, load capacity and age of the patient, and muscle chains to be stretched. to increase the standardization of treatment, it will be proposed only 2 or 3 postures.
Study: NCT05984524

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Gamma-Music Based Intervention
Description: Gamma or Control lights with Music-Based Intervention for 8 week period

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gamma-Music Based Intervention
Description: Gamma or Control lights with Music-Based Intervention for 8 week period
Study: NCT05578261

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: intermittent theta burst stimulation
Description: stimulatory protocol
Study: NCT04931732

Intervention type: BIOLOGICAL
Intervention: ctDNA analysis
Description: ctDNA analysis of patients with suspected primary glioma tumors and in patients with suspected recurrence.

Intervention type: BIOLOGICAL
Intervention: ctDNA analysis
Description: ctDNA analysis of patients with suspected primary glioma tumors and in patients with suspected recurrence.
Study: NCT05455541

Intervention type: DIAGNOSTIC_TEST
Intervention: AI augmented POCUS examination
Description: Internists will perform POCUS studies as they consider appropriate for patient management. Interpretation of the POCUS exams will be aided by machine learning based analysis of the videos.
Study: NCT05486182

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F Fluoroestradiol Radiopharmaceutical with PET/CT
Description: Administration of one dose of 18F FES for PET/CT imaging
Study: NCT04640376

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol Uniflash 125mg
Description: Oromucosal solution 1.25 mL for buccal use

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Panadol 500 MG Oral Tablet X1
Description: Tablet masked in capsule

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Panadol 500 MG Oral Tablet X2
Description: Tablet masked in capsule

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Dummy treatment
Study: NCT06182202

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Powered Prosthesis
Description: Custom in-house powered prosthetic device (used in prior studies, see Citations).
Study: NCT04741750

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simplified HCV care within a mobile medical unit
Description: Delivers guideline-based care for HCV in a stream-lined manner on a mobile medical unit
Study: NCT05280444

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin Hydrochloride for Injection
Description: The initial dose of idarubicin is 10 mg and the maximum tolerated dose is 20 mg. Idarubicin is first dissolved in water for injection to make a solvent of 2mg/ml, which is then mixed with lipiodol to make an emulsion with a ratio of 1:2. Lipiodol-idarubicin emulsion is slowly injected, followed by embolization with embolic agents.
Study: NCT05419219

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: the multi-domain Tai Chi Digital therapy Software Application
Description: regular Tai Chi exercise, 40 Hz gamma sound stimulation and 18 BPM breath control exercise

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: the multi-domain Tai Chi Digital therapy Software Application
Description: regular Tai Chi exercise, 40 Hz gamma sound stimulation and 18 BPM breath control exercise
Study: NCT06430567

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blood flow restriction (50% AOP compression) in the rehabilitation phase after Latarjet surgery for chronic shoulder instability
Description: Participants undergoing shoulder instability surgery (Latarjet procedure) by a single surgeon will receive standard physiotherapy (2 sessions per week) before being randomized into 3 groups at their 6th postoperative week check-up:~Group 1) BFR Group with 50% AOP compression~Group 1 will perform a 30-minute strengthening session twice weekly during postoperative weeks 7 to 14. They will do 4 exercises, completing 4 sets with 30-second rest intervals and 1 minute between exercises, following 30-15-15-15 at 40% 1RM (repetition maximum)~Exercise :~External rotation with pulley/band Internal rotation with pulley/band Frontal elevation with hyperpronation Diagonal abduction-external rotation with pulley/band~BFR training will use the MadUp© system, placing the band proximally on the operated arm, with a central unit continuously monitoring and calibrating arm pressure.
Study: NCT06152562

Intervention type: DIAGNOSTIC_TEST
Intervention: VerifyNow antiplatelet therapy response test
Description: VerifyNow testing after minimum of 2 hours and at latest 24 hours after the first four dosis of ASA
Study: NCT06536387

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Storytelling Through Music
Description: Storytelling Through Music is a six-week intervention that combines storytelling, reflective writing, song-writing, and self-care skills to improve emotion regulation through affective and cognitive coping skills.
Study: NCT03890432

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GLUCOSAFE 2
Description: Use of GLUCOSAFE 2 software for nutrition management and insulin-therapy

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Local protocol control group with routine care
Description: Use of the local protocols (electronic or paper version) for nutrition management and blood glucose control.

Intervention type: DEVICE
Group type: OTHER
Intervention: Historical control group with routine care
Description: Use of the local protocols (electronic or paper version) for nutrition management and blood glucose control.
Study: NCT05356000

Intervention type: OTHER
Group type: OTHER
Intervention: Special low-oxalate diet followed by all-day visit to University of Chicago research clinic
Description: Active participation in this study will last for around one week. For the first two days, participants will be asked to eat a special diet at home. From Days 3-5, they will eat special meals that will be delivered to their home from a research clinic at the University of Chicago. They will also collect urine at home on Days 4 and 5.~On Day 6, subjects will come in to the research clinic at the University of Chicago in Hyde Park, where they will spend most of the day. They will receive a special liquid that contains oxalate, and will receive a specially prepared breakfast that is low in oxalate and citrate. After this, we will collect their urine and blood throughout the day. We will draw blood 4 separate times.
Study: NCT05602844

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PSI Lapidus
Description: Design of PSI: DICOM files will be imported into the Model Intestinal Microflora in Computer Simulation (MIMICS 21.0) 3D image processing software (Materialize, Belgium) for 3D rendering. The segmented bone images will be used for design of the computer-aided modelling (CAM) surgical jigs. 3D printing of PSI jig. PSI-assisted Lapidus Surgery.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Lapidus
Description: exposure of the 1TMTJ via a 3-5cm medial longitudinal skin incision and capsulotomy. Freehand creation of the fusion surface with fluoroscopic assistance. Fixation of the Lapidus arthrodesis will be performed with two 3.5mm headless compression screws
Study: NCT05552248

Intervention type: DEVICE
Intervention: LumbarBelt SOFT 300
Description: 15 patients will be included in this group and will used the medical device LumbarBelt SOFT 300 during sport practice (at least 2 sport sessions per week), for 12 weeks.

Intervention type: OTHER
Intervention: Control group LumbarBelt SOFT 300
Description: 15 patients will be included in this control group and will performed their sport sessions as usual (without the medical device LumbarBelt SOFT 300), for at least 2 sport sessions per week during 12 weeks.

Intervention type: DEVICE
Intervention: LumbarBelt MID 500
Description: 15 patients will be included in this group and will used the medical device LumbarBelt MID 500 during sport practice (at least 2 sport sessions per week), for 12 weeks.

Intervention type: OTHER
Intervention: Control group LumbarBelt MID 500
Description: 15 patients will be included in this control group and will performed their sport sessions as usual (without the medical device LumbarBelt MID 500), for at least 2 sport sessions per week during 12 weeks.
Study: NCT06430567

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Blood flow restriction (10% AOP compression) in the rehabilitation phase after Latarjet surgery for chronic shoulder instability
Description: Participants undergoing shoulder instability surgery (Latarjet procedure) by a single surgeon will receive standard physiotherapy (2 sessions per week) before being randomized into 3 groups at their 6th postoperative week check-up:~Group 2) BFR Group with 10% AOP compression~Group 2 will perform a 30-minute strengthening session twice weekly during postoperative weeks 7 to 14. They will do 4 exercises, completing 4 sets with 30-second rest intervals and 1 minute between exercises, following 15-15-15-15 at 70% 1RM~Exercise :~External rotation with pulley/band Internal rotation with pulley/band Frontal elevation with hyperpronation Diagonal abduction-external rotation with pulley/band~BFR training will use the MadUp© system, placing the band proximally on the operated arm, with a central unit continuously monitoring and calibrating arm pressure.
Study: NCT06230926

Intervention type: OTHER
Intervention: Validity, Reliability and Adaptation
Description: The Hoehn \& Yahr Scale (HDS) and the Unified Parkinson's Disease Rating Scale (UPDRS) will be used for the clinical evaluation and disease staging of the individuals included in the study. In addition to the PDQoL-7 questionnaire, the 'Short Form-36' and 'Parkinson's Disease Questionnaire-39' questionnaires will be administered to patients to assess concurrent validity. Since at least 5-10 times the number of items in the questionnaire (7 items) must include at least 5-10 times the number of participants in order to perform factor analysis, a pretest of the questionnaire will be applied to individuals with PD with at least 35-70 participants. To determine the test-retest reliability, the PDQoL7 questionnaire will be administered again to the same patients after 2 weeks.
Study: NCT06231888

Intervention type: DEVICE
Intervention: Aligner
Description: Orthodontic alginer

Intervention type: DEVICE
Intervention: Aligner
Description: Orthodontic alginer
Study: NCT05587530

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment engagement and retention intervention for suicidal clients
Description: The manualized behavioral intervention for treatment engagement and retention of suicidal clients will be based on client and staff stakeholder preferences, informed by data from qualitative participatory interviews and secondary data analysis of administrative databases (conducted in phase 1). In addition to factors identified by stakeholders, if deemed feasible and acceptable during phase 1, the intervention will include structured phone outreach, shared decision-making, and peer support.
Study: NCT05586347

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicardipine
Description: Nicardipine 0.2-0.5μg/(kg·min) was infused at the beginning of CPB.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: It has the same capacity as group N。
Study: NCT04870216

Intervention type: OTHER
Intervention: Questionnaire regarding intimate protections habit.
Description: Questionnaire regarding intimate protections habit.
Study: NCT05042219

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac MRI
Description: Cardiac MRI and Echocardiography before treatment initiation of pulmonary disease and 3 months thereafter

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac MRI
Description: Cardiac MRI and Echocardiography before treatment initiation of pulmonary disease and 3 months thereafter

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac MRI
Description: Cardiac MRI and Echocardiography before treatment initiation of pulmonary disease and 3 months thereafter

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac MRI
Description: Cardiac MRI and Echocardiography before treatment initiation of pulmonary disease and 3 months thereafter

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac MRI
Description: Cardiac MRI and Echocardiography before treatment initiation of pulmonary disease and 3 months thereafter

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac MRI
Description: Cardiac MRI and Echocardiography before treatment initiation of pulmonary disease and 3 months thereafter
Study: NCT04640376

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Dummy treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Dummy treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dummy treatment
Study: NCT04341779

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Point-of-care viral load testing and tenofovir adherence testing
Description: Point-of-care testing of HIV viral load and tenofovir, and providing same day results to participants
Study: NCT06580886

Intervention type: DEVICE
Intervention: Ultrasound
Description: All patients having ultrasound with Clarius L15/L20 and GE logic E9/E10 in same visit.
Study: NCT05430750

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrous oxide
Description: In conventional nitrous oxide carrier group 2% Sevoflurane in O2-N2O (60 % FiO2) @3L/min will be delivered to achieve MAC 0.5.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrous oxide
Description: In streamed-in nitrous oxide carrier group 2% Sevoflurane in O2 -Air (60 % FiO2) will be delivered @3.0L/min to achieve a MAC of 0.5. Then, the FGF will be decreased to 1.0 L (low flow) and N2O will be 'streamed-in' @ 40 %.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Ventilation will be initiated with 2% sevoflurane in all the groups

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Ventilation will be initiated with 2% sevoflurane in all the groups

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Ventilation will be initiated with 2% sevoflurane in all the groups
Study: NCT05135910

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hallux Terbinafine Subungual Gel
Description: Hallux Terbinafine Subungual Gel (HSG) administered every 1 to 2 months over 44 weeks.
Study: NCT06580912

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Krill oil
Description: 4 grams of krill oil per day

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Mixed vegetable oil
Description: 4 grams of mixed vegetable oil per day
Study: NCT06188364

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of Care
Description: The usual Transition Supports and Services (USS) that prepare care partners of persons with TBI for post-rehabilitation discharge, so the the delivery of traditional CHW outreach services such as finding health, community and social determinants referrals, problem-solving, and connecting care partners to long-term supports/services

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Novel aspects of the CHW experimental intervention for TBI care partners include:~1. CHW services begin prior to inpatient rehabilitation discharge;~2. care partners get timely, useful health management materials;~3. encounters focus on unlimited, brief, situation-focused calls to help care partners assess and resolve pressing concerns; and~4. long-term support capacity for care partners is built by establishing a reliable referral network of medical, community, and social services that become foundational resources beyond study completion.
Study: NCT04580940

Intervention type: DEVICE
Intervention: SpyGlass™ Discover Digital System
Description: Observational, prospective, registry study for the clinical utility of the SpyGlass Discover digital catheter during a PTCS procedure.